As the National Director of Specialty Accounts and Patient Engagement at AvevoRx, Norma Gowdy plays a pivotal role in advancing patient access to critical specialty medications. With over a decade of experience in the healthcare sector, particularly in buy and bill processes and infusion therapies,...
As the National Director of Specialty Accounts and Patient Engagement at AvevoRx, Norma Gowdy plays a pivotal role in advancing patient access to critical specialty medications. With over a decade of experience in the healthcare sector, particularly in buy and bill processes and infusion therapies, Norma has honed her expertise in navigating the complexities of healthcare reimbursement. Her deep understanding of payer dynamics and utilization of patient assistance programs enables her to effectively advocate for patients with rare diseases, ensuring they receive the necessary treatments without undue financial burden.
At AvevoRx, an independent infusion-focused specialty pharmacy, Norma leads key initiatives that bridge the gap between patients, healthcare providers, and payers. Her current projects include developing strategic partnerships with physicians to enhance patient engagement and streamline access to therapies such as IVIG/SCIG and anti-TNF treatments. By leveraging her skills in strategic planning and data analysis, she is able to identify trends and implement solutions that optimize patient outcomes while stewarding payer dollars responsibly.
Norma's passion for patient advocacy is evident in her commitment to building strong relationships with both patients and healthcare providers. She believes that effective communication and collaboration are essential in navigating the complexities of the healthcare landscape. As she continues to expand her role at AvevoRx, Norma remains dedicated to empowering patients and ensuring they have the support they need to manage their health journeys successfully. Her multifaceted approach not only enhances patient access but also contributes to the overall mission of improving healthcare delivery in the specialty pharmacy sector.
